NBIX - Neurocrine Biosciences Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - NBIX (914475)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
100 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2024-05-17
NBIXSharp ShaliniDirS - Sale+OE$141.90-1,106994-53%-$156,943
D
2024-05-17
NBIXPops Richard FDirS - Sale+OE$141.84-2,10031,611-6%-$297,860
D
2024-05-17
NBIXNorwalk Leslie VDirS - Sale+OE$141.82-1,106994-53%-$156,850
D
2024-05-14
NBIXLyons Gary ADirS - Sale+OE$135.63-12,500116,947-10%-$1,695,370
DM
2024-05-14
NBIXAbernethy MattCFOS - Sale+OE$137.95-30,00031,528-49%-$4,138,436
D
2024-05-06
NBIXDelaet IngridChief Regulatory OfficerS - Sale+OE$140.55-2737,507-4%-$38,370
D
2024-04-15
NBIXBenevich EricChief Commercial OfficerS - Sale+OE$133.37-19,81840,778-33%-$2,643,020
D
2024-04-01
NBIXDelaet IngridChief Regulatory OfficerS - Sale+OE$137.30-2727,507-3%-$37,346
D
2024-03-21
NBIXDelaet IngridChief Regulatory OfficerS - Sale+OE$145.06-5,0007,507-40%-$725,320
D
2024-03-14
NBIXBenevich EricChief Commercial OfficerS - Sale+OE$139.38-75,00040,778-65%-$10,453,418
D
2024-03-14
NBIXMorrow George JDirS - Sale+OE$139.42-40,0000-100%-$5,576,710
D
2024-03-13
NBIXPops Richard FDirS - Sale+OE$140.33-23,20029,512-44%-$3,255,621
D
2024-03-13
NBIXDelaet IngridChief Regulatory OfficerS - Sale+OE$140.14-3,0007,507-29%-$420,419
DM
2024-03-08
NBIXPops Richard FDirS - Sale+OE$140.04-1,80029,512-6%-$252,078
DM
2024-03-08
NBIXDelaet IngridChief Regulatory OfficerS - Sale+OE$140.03-2,0007,507-21%-$280,053
DM
2024-02-28
NBIXDelaet IngridChief Regulatory OfficerS - Sale+OE$135.34-6,8177,507-48%-$922,632
D
2024-02-28
NBIXBenevich EricChief Commercial OfficerS - Sale+OE$134.69-75,00040,616-65%-$10,101,608
D
2024-02-27
NBIXNorwalk Leslie VDirS - Sale+OE$135.67-8,0000-100%-$1,085,388
D
2024-02-20
NBIXPops Richard FDirS - Sale+OE$132.47-15,00029,512-34%-$1,987,047
D
2024-02-13
NBIXRoberts EiryChief Medical OfficerS - Sale+OE$132.96-1,11423,716-4%-$148,122
D
2024-02-13
NBIXOnyia JudeChief Scientific OfficerS - Sale+OE$132.94-1,43213,128-10%-$190,371
D
2024-02-13
NBIXLippoldt DarinGCS - Sale+OE$133.00-1,09839,740-3%-$146,028
D
2024-02-13
NBIXGorman Kevin CharlesCEOS - Sale+OE$133.02-2,832514,596-1%-$376,700
D
2024-02-13
NBIXGano KyleChief Business Development OffS - Sale+OE$132.90-1,352135,166-1%-$179,674
D
2024-02-13
NBIXDelaet IngridChief Regulatory OfficerS - Sale+OE$133.04-7167,507-9%-$95,253
D
2024-02-13
NBIXCooke JulieCHROS - Sale+OE$133.04-79617,976-4%-$105,902
D
2024-02-13
NBIXBoyer David W.Chief Corp. Affairs OfficerS - Sale+OE$133.07-1,8114,895-27%-$240,996
D
2024-02-13
NBIXBenevich EricChief Commercial OfficerS - Sale+OE$133.02-1,09840,616-3%-$146,050
D
2024-02-13
NBIXAbernethy MattCFOS - Sale+OE$132.85-1,35231,528-4%-$179,612
M
2024-02-06
NBIXBoyer David W.Chief Corp. Affairs OfficerS - Sale$137.09-1,7844,895-27%-$244,564
M
2024-02-06
NBIXCooke JulieCHROS - Sale$138.61-2,54417,263-13%-$352,612
M
2024-02-06
NBIXRoberts EiryChief Medical OfficerS - Sale$138.49-2,10122,717-8%-$290,968
M
2024-02-06
NBIXLippoldt DarinGCS - Sale$138.47-1,95238,755-5%-$270,284
M
2024-02-06
NBIXGorman Kevin CharlesCEOS - Sale$138.74-5,314506,962-1%-$737,271
M
2024-02-06
NBIXGano KyleChief Business Development OffS - Sale$139.16-2,580133,952-2%-$359,041
M
2024-02-06
NBIXBenevich EricChief Commercial OfficerS - Sale$138.68-2,26039,631-5%-$313,419
M
2024-02-06
NBIXAbernethy MattCFOS - Sale$138.73-2,26030,314-7%-$313,530
2024-01-31
NBIXRoberts EiryChief Medical OfficerS - Sale$140.79-1,45720,832-7%-$205,132
2024-01-31
NBIXOnyia JudeChief Scientific OfficerS - Sale$141.94-12611,843-1%-$17,884
2024-01-31
NBIXLippoldt DarinGCS - Sale$140.65-1,25037,005-3%-$175,810
2024-01-31
NBIXGorman Kevin CharlesCEOS - Sale$140.69-2,707502,188-1%-$380,845
2024-01-31
NBIXGano KyleChief Business Development OffS - Sale$140.70-1,541131,635-1%-$216,813
M
2024-01-31
NBIXDelaet IngridChief Regulatory OfficerS - Sale$140.65-1,0456,865-13%-$146,975
2024-01-31
NBIXCooke JulieCHROS - Sale$141.29-1,74017,263-9%-$245,842
2024-01-31
NBIXBoyer David W.Chief Corp. Affairs OfficerS - Sale$140.80-2,0964,894-30%-$295,115
2024-01-31
NBIXBenevich EricChief Commercial OfficerS - Sale$140.78-1,20737,601-3%-$169,927
2024-01-31
NBIXAbernethy MattCFOS - Sale$140.72-1,28328,284-4%-$180,539
D
2024-01-22
NBIXLippoldt DarinGCS - Sale+OE$139.86-10,00035,882-22%-$1,398,553
DM
2024-01-08
NBIXGorman Kevin CharlesCEOS - Sale+OE$133.02-167,858499,754-25%-$22,328,417
D
2024-01-02
NBIXGano KyleChief Business Development OffS - Sale+OE$131.47-75,000130,250-37%-$9,860,194
D
2024-01-02
NBIXRastetter William HDirS - Sale+OE$131.47-11,04451,741-18%-$1,451,927
2023-12-22
NBIXRoberts EiryChief Medical OfficerS - Sale$126.75-10,00019,521-34%-$1,267,448
2023-12-22
NBIXLyons Gary ADirS - Sale$130.04-10,000193,697-5%-$1,300,443
D
2023-12-22
NBIXCooke JulieCHROS - Sale+OE$128.66-24,00017,263-58%-$3,087,808
D
2023-12-12
NBIXRoberts EiryChief Medical OfficerS - Sale+OE$120.30-13,92529,521-32%-$1,675,240
DM
2023-12-07
NBIXRoberts EiryChief Medical OfficerS - Sale+OE$120.37-77,67929,521-72%-$9,350,350
D
2023-12-06
NBIXRoberts EiryChief Medical OfficerS - Sale+OE$120.03-8,39629,521-22%-$1,007,780
D
2023-12-06
NBIXLippoldt DarinGCS - Sale+OE$119.86-20,83035,882-37%-$2,496,648
D
2023-12-01
NBIXLyons Gary ADirS - Sale+OE$116.77-5,000203,697-2%-$583,837
2023-11-29
NBIXOnyia JudeChief Scientific OfficerS - Sale$113.57-2,33111,732-17%-$264,733
2023-11-27
NBIXLippoldt DarinGCS - Sale$112.27-10,91935,882-23%-$1,225,911
2023-10-02
NBIXBoyer David W.Chief Corp. Affairs OfficerS - Sale$112.68-1,4374,894-23%-$161,921
D
2023-09-12
NBIXLyons Gary ADirS - Sale+OE$115.02-5,000203,697-2%-$575,120
D
2023-09-01
NBIXLyons Gary ADirS - Sale+OE$110.06-5,000203,697-2%-$550,316
2023-09-01
NBIXCooke JulieCHROS - Sale$110.93-82417,263-5%-$91,406
2023-08-30
NBIXBoyer David W.Chief Corp. Affairs OfficerS - Sale$107.60-2,7333,460-44%-$294,058
2023-08-28
NBIXDelaet IngridChief Regulatory OfficerS - Sale$107.52-1,4315,931-19%-$153,861
2023-08-21
NBIXRoberts EiryChief Medical OfficerS - Sale$107.38-3,19829,521-10%-$343,388
2023-08-21
NBIXOnyia JudeChief Scientific OfficerS - Sale$107.37-3,1989,638-25%-$343,368
2023-08-21
NBIXLippoldt DarinGCS - Sale$107.39-2,13246,991-4%-$228,951
2023-08-21
NBIXGorman Kevin CharlesCEOS - Sale$107.40-9,328499,754-2%-$1,001,816
2023-08-21
NBIXGano KyleChief Business Development OffS - Sale$107.41-2,132130,250-2%-$228,993
2023-08-21
NBIXDelaet IngridChief Regulatory OfficerS - Sale$107.42-1,4044,645-23%-$150,820
2023-08-21
NBIXCooke JulieCHROS - Sale$107.41-2,13218,087-11%-$228,991
2023-08-21
NBIXBoyer David W.Chief Corp. Affairs OfficerS - Sale$107.41-1,6006,193-21%-$171,862
2023-08-21
NBIXBenevich EricChief Commercial OfficerS - Sale$107.40-1,60036,436-4%-$171,836
2023-08-21
NBIXAbernethy MattCFOS - Sale$107.39-2,13227,131-7%-$228,958
D
2023-05-01
NBIXRastetter William HDirS - Sale+OE$101.43-4,30042,785-9%-$436,135
2023-05-01
NBIXCooke JulieCHROS - Sale$103.89-11,39716,169-41%-$1,184,049
2023-04-25
NBIXCooke JulieCHROS - Sale$103.82-10027,5610%-$10,382
2023-04-24
NBIXRoberts EiryChief Medical OfficerS - Sale$103.48-14,40026,644-35%-$1,490,059
DM
2023-04-19
NBIXRastetter William HDirS - Sale+OE$105.03-6,93739,460-15%-$728,605
M
2023-02-06
NBIXCooke JulieCHROS - Sale$102.77-17,07927,424-38%-$1,755,121
M
2023-02-06
NBIXRoberts EiryChief Medical OfficerS - Sale$102.74-16,52541,015-29%-$1,697,707
2023-02-07
NBIXOnyia JudeChief Scientific OfficerS - Sale$102.30-4,5086,525-41%-$461,166
M
2023-02-06
NBIXLloyd-Smith MalcolmChief Integration OfficerS - Sale$102.64-15,31842,337-27%-$1,572,197
M
2023-02-06
NBIXLippoldt DarinGCS - Sale$102.71-16,27544,973-27%-$1,671,637
M
2023-02-06
NBIXGorman Kevin CharlesCEOS - Sale$102.90-29,044491,365-6%-$2,988,758
M
2023-02-06
NBIXGano KyleChief Business Development OffS - Sale$102.80-17,004128,096-12%-$1,747,920
M
2023-02-06
NBIXBoyer David W.Chief Corp. Affairs OfficerS - Sale$102.49-25,2384,755-84%-$2,586,741
M
2023-02-06
NBIXBenevich EricChief Commercial OfficerS - Sale$102.70-19,65034,381-36%-$2,018,105
M
2023-02-06
NBIXAbernethy MattCFOS - Sale$102.61-28,58825,213-53%-$2,933,470
2023-01-31
NBIXRoberts EiryChief Medical OfficerS - Sale$109.99-1,45726,171-5%-$160,254
2023-01-31
NBIXOnyia JudeChief Scientific OfficerS - Sale$108.48-1262,477-5%-$13,668
2023-01-31
NBIXLloyd-Smith MalcolmChief Integration OfficerS - Sale$110.02-1,66628,582-6%-$183,290
2023-01-31
NBIXLippoldt DarinGCS - Sale$109.97-1,25030,357-4%-$137,464
2023-01-31
NBIXGorman Kevin CharlesCEOS - Sale$110.08-2,707465,278-1%-$297,997
2023-01-31
NBIXGano KyleChief Business Development OffS - Sale$109.99-1,541112,820-1%-$169,486
2023-01-31
NBIXCooke JulieCHROS - Sale$108.48-91615,926-5%-$99,368
2023-01-31
NBIXBoyer David W.Chief Corp. Affairs OfficerS - Sale$109.92-1,1043,911-22%-$121,349

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top